A phase II study of weekly irinotecan in patients with locally advanced or metastatic HER2- negative breast cancer and increased copy numbers of the topoisomerase 1 (TOP1) gene: a...

Por Kümler, Iben, Balslev, Eva, Stenvang, Jan, Brünner, Nils, Nielsen, Dorte
Publicado no BMC Cancer (2015)

Screening for colorectal cancer: possible improvements by risk assessment evaluation?

Por Nielsen, Hans J, Jakobsen, Karen V, Christensen, IB J, Brünner, Nils
Publicado em 2011

Plasminogen Activator Inhibitor 1 Protects Fibrosarcoma Cells from Etoposide-Induced Apoptosis through Activation of the PI3K/Akt Cell Survival Pathway

Por Rømer, Maria U, Larsen, Lise, Offenberg, Hanne, Brünner, Nils, Lademann, Ulrik A
Publicado em 2008

Lack of relationship between TIMP-1 tumour cell immunoreactivity, treatment efficacy and prognosis in patients with advanced epithelial ovarian cancer

Por Steffensen, Karina Dahl, Waldstrøm, Marianne, Christensen, Rikke Kølby, Bartels, Annette, Brünner, Nils, Jakobsen, Anders
Publicado em 2010

Human epidermal growth factor receptor 2 (HER2) immunoreactivity: specificity of three pharmacodiagnostic antibodies

Por Schrohl, Anne-Sofie, Pedersen, Hans Christian, Jensen, Sussie Steen, Nielsen, Signe Lykke, Brünner, Nils
Publicado em 2011

Comparative Analysis of Evolutionarily Conserved Motifs of Epidermal Growth Factor Receptor 2 (HER2) Predicts Novel Potential Therapeutic Epitopes

Por Deng, Xiaohong, Zheng, Xuxu, Yang, Huanming, Moreira, José Manuel Afonso, Brünner, Nils, Christensen, Henrik
Publicado em 2014

Tumor tissue levels of Tissue Inhibitor of Metalloproteinases-1 (TIMP-1) and outcome following adjuvant chemotherapy in premenopausal lymph node-positive breast cancer patients: A...

Por Schrohl, Anne-Sofie, Look, Maxime P, Meijer-van Gelder, Marion E, Foekens, John A, Brünner, Nils
Publicado em 2009

Tissue inhibitor of metalloproteinases-1-induced scattered liver metastasis is mediated by host-derived urokinase-type plasminogen activator

Por Schrötzlmair, Florian, Kopitz, Charlotte, Halbgewachs, Birgit, Lu, Fei, Algül, Hana, Brünner, Nils, Gänsbacher, Bernd, Krüger, Achim
Publicado em 2010

Characterization of Anti-TIMP-1 Monoclonal Antibodies for Immunohistochemical Localization in Formalin-fixed, Paraffin-embedded Tissue

Por Sorensen, Irene Vejgaard, Fenger, Claus, Winther, Henrik, Foged, Niels T., Lademann, Ulrik, Brünner, Nils, Usher, Pernille A.
Publicado em 2006

Data fusion in metabolomic cancer diagnostics

Por Bro, Rasmus, Nielsen, Hans Jørgen, Savorani, Francesco, Kjeldahl, Karin, Christensen, Ib Jarle, Brünner, Nils, Lawaetz, Anders Juul
Publicado em 2012

Is TIMP-1 immunoreactivity alone or in combination with other markers a predictor of benefit from anthracyclines in the BR9601 adjuvant breast cancer chemotherapy trial?

Por Munro, Alison F, Bartels, Annette, Balslev, Eva, Twelves, Christopher J, Cameron, David A, Brünner, Nils, Bartlett, John MS
Publicado em 2013

Biomarker-Guided Repurposing of Chemotherapeutic Drugs for Cancer Therapy: A Novel Strategy in Drug Development

Por Stenvang, Jan, Kümler, Iben, Nygård, Sune Boris, Smith, David Hersi, Nielsen, Dorte, Brünner, Nils, Moreira, José M. A.
Publicado em 2013

High frequency of tumor cells with nuclear Egr-1 protein expression in human bladder cancer is associated with disease progression

Por Egerod, Frederikke Lihme, Bartels, Annette, Fristrup, Niels, Borre, Michael, Ørntoft, Torben F, Oleksiewicz, Martin B, Brünner, Nils, Dyrskjøt, Lars
Publicado em 2009

Association between plasma concentrations of plasminogen activator inhibitor-1 and survival in patients with colorectal cancer

Por Nielsen, Hans Jørgen, Pappot, Helle, Christensen, Ib Jarle, Brünner, Nils, Thorlacius-Ussing, Ole, Moesgaard, Flemming, Danø, Keld, Grøndahl-Hansen, Jan
Publicado em 1998

Banking of Biological Fluids for Studies of Disease-associated Protein Biomarkers

Por Schrohl, Anne-Sofie, Würtz, Sidse, Kohn, Elise, Banks, Rosamonde E., Nielsen, Hans Jørgen, Sweep, Fred C. G. J., Brünner, Nils
Publicado em 2008

TIMP-1 and responsiveness to gemcitabine in advanced breast cancer; results from a randomized phase III trial from the Danish breast cancer cooperative group

Por Jørgensen, Charlotte Levin Tykjær, Bjerre, Christina, Ejlertsen, Bent, Bjerre, Karsten D, Balslev, Eva, Bartels, Annette, Brünner, Nils, Nielsen, Dorte L
Publicado em 2014

Comparative studies of TIMP-1 immunohistochemistry, TIMP-1 FISH analysis and plasma TIMP-1 in glioblastoma patients

Por Aaberg-Jessen, Charlotte, Halle, Bo, Jensen, Stine S., Müller, Sven, Rømer, Unni Maria, Pedersen, Christian B., Brünner, Nils, Kristensen, Bjarne W.
Publicado no J Neurooncol (2016)

An explorative analysis of ERCC1-19q13 copy number aberrations in a chemonaive stage III colorectal cancer cohort

Por Smith, David Hersi, Christensen, Ib Jarle, Jensen, Niels Frank, Markussen, Bo, Müller, Sven, Nielsen, Hans Jørgen, Brünner, Nils, Nielsen, Kirsten Vang
Publicado em 2013

The glutamate transport inhibitor DL-Threo-β-Benzyloxyaspartic acid (DL-TBOA) differentially affects SN38- and oxaliplatin-induced death of drug-resistant colorectal cancer cells

Por Pedraz-Cuesta, Elena, Christensen, Sandra, Jensen, Anders A., Jensen, Niels Frank, Bunch, Lennart, Romer, Maria Unni, Brünner, Nils, Stenvang, Jan, Pedersen, Stine Falsig
Publicado no BMC Cancer (2015)

High levels of microRNA-21 in the stroma of colorectal cancers predict short disease-free survival in stage II colon cancer patients

Por Nielsen, Boye Schnack, Jørgensen, Stine, Fog, Jacob Ulrik, Søkilde, Rolf, Christensen, Ib Jarle, Hansen, Ulla, Brünner, Nils, Baker, Adam, Møller, Søren, Nielsen, Hans Jørgen
Publicado em 2010